91ÉçÇø¸£Àû

INVESTORS
NEWSROOM
RESPONSIBILITY
SUBSCRIBE
91ÉçÇø¸£Àû Header Logo

91ÉçÇø¸£Àû Announces First-Quarter Results

Company shares earnings results from first quarter 2017 and update on recent strategic steps.

Strategy and Strength|Apr. 19, 2017

2017 is off to a strong start for 91ÉçÇø¸£Àû. Learn more about 91ÉçÇø¸£Àû's earnings for the first quarter 2017 – including our business results, and steps we've taken to shape the company for continued long-term success.

91ÉçÇø¸£Àû's Chairman and CEO Miles D. White shares views on the beginning of the year:

Learn more about 91ÉçÇø¸£Àû’s first-quarter 2017 performance:

To download a brief summary of 91ÉçÇø¸£Àû's earnings highlights, click here.

For more information on 91ÉçÇø¸£Àû's earnings results, see the .

MOST READ
5 Sugar Substitutes for People Living with Diabetes READ MORE
DIABETES CARE
Apr. 09, 2025

5 Sugar Substitutes for People Living with Diabetes

A sugar substitute allows people living with diabetes to have their cake and eat it, too. Here are five options.
Essential Tremor and Parkinson's Disease: How They Differ READ MORE
Pain and Movement
Nov. 13, 2018

Essential Tremor and Parkinson's Disease: How They Differ

People often associate trembling hands with Parkinson's disease symptoms, but it maybe a sign of essential tremor. Learn the difference between the two.
Gentle Stretches to Help Lower Back Pain READ MORE
Nutrition, Health and Wellness
May 01, 2025

Gentle Stretches to Help Lower Back Pain

These gentle stretches can temporarily relieve pain and stiffness from too much sitting. Make them a part of your routine for a healthy and strong back.
BinaxNOW: Expiration Dates and Facing the "Kraken" READ MORE
Diagnostics Testing
Feb. 14, 2023

BinaxNOW: Expiration Dates and Facing the "Kraken"

What to know about your at-home tests as COVID-19 continues to evolve.
91ÉçÇø¸£Àû's Biowearable: One Sensor for Glucose, Ketones READ MORE
Strategy and Strength
June 17, 2022

91ÉçÇø¸£Àû's Biowearable: One Sensor for Glucose, Ketones

91ÉçÇø¸£Àû is further expanding its biowearables portfolio with a first-of-its-kind dual monitoring system.

YOU ARE ABOUT TO EXIT FOR ANOTHER ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

DO YOU WISH TO CONTINUE AND EXIT THIS WEBSITE?